GW Pharmaceuticals (GWPH)
151.25
+0.24 +0.16%
NASDAQ
Jun 22, 20:00
Delayed 2m
USD
View All Key Stats
GWPH Key Stats
| Income Statement | |
| Revenue (TTM) | 16.82M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -9.654 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -255.22M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 51.15% |
| Profit Margin (Quarterly) | -2.63K% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 4.266B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 235.80 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 7.621 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | -75.46M |
| Return on Equity (TTM) | Upgrade |
View All GWPH News
GWPH News
-
WireHeadlineTime (ET)
-
SA Breaking News06/22 14:32
-
PR Newswire06/21 10:30
-
PR Newswire06/20 09:00
-
SA Breaking News06/20 08:36
-
SA Breaking News06/20 06:32
-
MT Newswires06/18 11:06
-
Yahoo06/14 11:59
-
Yahoo06/14 07:09
-
PR Newswire06/13 09:00
-
MT Newswires06/12 11:33
View All Events
GWPH Events
| Date | Type | Description |
|---|---|---|
| 12/04/2018 07:30 EST | Misc | GW Pharmaceuticals PLC Fourth Quarter Earnings Conference Call in 2018 |
| 12/04/2018 | Earnings | GW Pharmaceuticals PLC Fourth Quarter Earnings in 2018 Release |
| 02/05/2018 | Earnings | GW Pharmaceuticals PLC First Quarter Earnings in 2018 Release |
| 02/05/2018 | Misc | GW Pharmaceuticals PLC First Quarter Earnings Conference Call in 2018 |
| 12/04/2017 07:30 EST | Misc | GW Pharmaceuticals PLC Fourth Quarter Earnings Conference Call in 2017 |
| 12/04/2017 | Earnings | GW Pharmaceuticals PLC Fourth Quarter Earnings in 2017 Release |
| 08/07/2017 16:30 EDT | Misc | GW Pharmaceuticals PLC Third Quarter Earnings Conference Call in 2017 |
| 08/07/2017 | Earnings | GW Pharmaceuticals PLC Third Quarter Earnings in 2017 Release |
GWPH Fundamentals
Income Statement View Statement
GWPH Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
GWPH One Page Reports
- One Page Report Download
GWPH Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 151.25 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Edit
Profile
- URL: http://www.gwpharm.com
- Investor Relations URL: http://ir.gwpharm.com/
- HQ State/Province: N/A
- Sector: Healthcare
- Industry: Drug Manufacturers - Major
- Equity Style: Mid Cap/Value
- Next Earnings Release: Dec. 04, 2018
- Last Earnings Release: Feb. 05, 2018
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: GW Pharmaceuticals PLC is engaged in the research, development and commercialisation of cannabinoid prescription medicines using botanical extracts derived from the Cannabis Sativa plant.
GWPH Excel Add-In Codes
- Name: =YCI("GWPH","name")
- Description: =YCI("GWPH","description")
- Sector: =YCI("GWPH","sector")
- Industry: =YCI("GWPH","industry")
- Est. Current Fiscal Year End: =YCI("GWPH","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other GWPH Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- GWPH Tweets Stocktwits
Advertisement
